First Do No Harm: Is It Safe to Use Immunosuppressants in Inflammatory Bowel Disease Patients With Prior Cancer?

被引：3
作者：
Nguyen, Geoffrey C. [1 ]
机构：
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
来源：
GASTROENTEROLOGY | 2016年 / 151卷 / 01期
关键词：
NONMELANOMA SKIN-CANCER; COMBINATION THERAPY; RISK; AZATHIOPRINE; EPIDEMIOLOGY; INFLIXIMAB; AGENTS;
D O I：
10.1053/j.gastro.2016.05.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：22 / 24
页数：4
相关论文
共 50 条
  • [21] Vaccines and recommendations for their use in inflammatory bowel disease
    Dolores Sanchez-Tembleque, Maria
    Corella, Carmen
    Perez-Calle, Jose L.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (09) : 1354 - 1358
  • [22] Management of colorectal cancer in patients with inflammatory bowel disease
    Kavanagh, D. O.
    Carter, M. C.
    Keegan, D.
    Doherty, G.
    Smith, M. J.
    Hyland, J. M. P.
    Mulcahy, H.
    Sheahan, K.
    O' Connell, P. R.
    O' Donoghue, D. P.
    Winter, D. C.
    TECHNIQUES IN COLOPROCTOLOGY, 2014, 18 (01) : 23 - 28
  • [23] Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
    Yao, Ling-Ya
    Shao, Bu-Le
    Tian, Feng
    Ye, Mei
    Li, Yu-Qin
    Wang, Xiao-Lei
    Wang, Lin
    Yang, Shao-Qi
    Lv, Xiao-Ping
    Jia, Yan
    Wang, Xue-Hong
    Zhang, Xiao-Qi
    Wei, Yan-Ling
    Cao, Qian
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (30) : 4102 - 4119
  • [24] Optimising use of thiopurines in inflammatory bowel disease
    Dart, Robin J.
    Irving, Peter M.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2017, 13 (09) : 877 - 888
  • [25] Use of thiopurines in inflammatory bowel disease: an update
    Singh, Arshdeep
    Mahajan, Ramit
    Kedia, Saurabh
    Dutta, Amit Kumar
    Anand, Abhinav
    Bernstein, Charles N.
    Desai, Devendra
    Pai, C. Ganesh
    Makharia, Govind
    Tevethia, Harsh Vardhan
    Mak, Joyce W. Y.
    Kaur, Kirandeep
    Peddi, Kiran
    Ranjan, Mukesh Kumar
    Arkkila, Perttu
    Kochhar, Rakesh
    Banerjee, Rupa
    Sinha, Saroj Kant
    Ng, Siew Chien
    Hanauer, Stephen
    Verma, Suhang
    Dutta, Usha
    Midha, Vandana
    Mehta, Varun
    Ahuja, Vineet
    Sood, Ajit
    INTESTINAL RESEARCH, 2022, 20 (01) : 11 - 30
  • [26] The Optimal Management of Inflammatory Bowel Disease in Patients with Cancer
    Wetwittayakhlang, Panu
    Tselekouni, Paraskevi
    Al-Jabri, Reem
    Bessissow, Talat
    Lakatos, Peter L.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [27] Surveillance for colorectal cancer in patients with inflammatory bowel disease
    Hurley, Joanna J.
    Turner, Jeff
    Berrill, James
    Swift, Gillian
    Dolwani, Sunil
    Green, John
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (10) : 562 - 567
  • [28] Influence of comorbidities on treatment considerations for first-line biologic prescribing in patients with inflammatory bowel disease in the UK
    Akbar, Ayesha
    Orchard, Tim
    Powell, Nick
    Selinger, Christian
    Tibbatts, Clare
    FRONTLINE GASTROENTEROLOGY, 2022, 13 (06) : 490 - 496
  • [29] Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease
    Clare, Donnellan F.
    Alexander, Ford C.
    Mike, Sprakes
    Dan, Greer
    Allan, Fairclough
    Lisa, Warren
    Peter, Hamlin J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2009, 21 (01) : 71 - 75
  • [30] Inpatient Costs for Patients with Inflammatory Bowel Disease and Acute Pancreatitis
    Alexoff, Aimee
    Roginsky, Grigory
    Zhou, Ying
    Kalenda, Michelle
    Minuskin, Kelly
    Ehrenpreis, Eli D.
    INFLAMMATORY BOWEL DISEASES, 2016, 22 (05) : 1095 - 1100
12345